280 related articles for article (PubMed ID: 8030062)
1. Allograft ultraviolet-B irradiation in rat small intestinal transplantation.
Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
Transplant Proc; 1994 Jun; 26(3):1624-5. PubMed ID: 8030062
[No Abstract] [Full Text] [Related]
2. The effect of ultraviolet B-irradiated leukocyte transfusions in intestinal transplantation.
Xiao F; Foster PF; Sankary HN; Kociss K; Templeton AC; Williams JW
Transplant Proc; 1992 Jun; 24(3):1167-8. PubMed ID: 1604572
[No Abstract] [Full Text] [Related]
3. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
[No Abstract] [Full Text] [Related]
4. Failure of donor irradiation to prolong allograft survival in small bowel transplantation in rats.
Lee TK; Langrehr JM; Moynihan HL; Stangl MJ; Lee KK; Schraut WH
Transplant Proc; 1992 Jun; 24(3):1183-4. PubMed ID: 1604579
[No Abstract] [Full Text] [Related]
5. Selective mesenteric lymphoid irradiation eliminates the effector cells of lethal graft-versus-host disease while protecting radiosensitive intestinal tissue.
Hasuike Y; Shaked A; Monden M; Shiraishi M; Farmer D; Holly EG; Busuttil RW
Transplant Proc; 1993 Feb; 25(1 Pt 2):1196-7. PubMed ID: 8442085
[No Abstract] [Full Text] [Related]
6. Immunosuppression by combined liver transplantation in the rat mechanisms of graft acceptance and regulation of graft-vs-host disease.
Kobayashi E; Kamada N; Enosawa S; Toyama N; Lord R; Stamatiou S; Delriviere L; Miyata M
Transplant Proc; 1994 Jun; 26(3):1575-7. PubMed ID: 8030042
[No Abstract] [Full Text] [Related]
7. Leflunomide immunosuppression in rat small intestinal transplantation.
Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
[No Abstract] [Full Text] [Related]
8. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
[No Abstract] [Full Text] [Related]
9. Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation.
Greenstein SM; Sun SC; Senitzer D; Schechner RS; Tellis VA
Transplant Proc; 1993 Feb; 25(1 Pt 1):490-1. PubMed ID: 8438391
[No Abstract] [Full Text] [Related]
10. Amelioration of graft-versus-host disease following bowel transplantation with recipient specific leukocyte transfusion.
Xiao F; Foster PF; Sankary HN; Kociss K; Williams JW
Transplant Proc; 1992 Jun; 24(3):1192-3. PubMed ID: 1604582
[No Abstract] [Full Text] [Related]
11. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion.
Murase N; Ye Q; Lee RG; Demetris AJ; Abu-Elmagd K; Reyes J; Starzl TE
Transplant Proc; 1999; 31(1-2):565-6. PubMed ID: 10083238
[No Abstract] [Full Text] [Related]
12. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
[No Abstract] [Full Text] [Related]
13. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
[No Abstract] [Full Text] [Related]
14. The interaction of gamma irradiation of the allograft and recipient administration of cyclosporine in rat small bowel transplantation.
Foster PF; Sankary HN; Kociss K; Xiao F; Williams JW
Transplant Proc; 1992 Jun; 24(3):1175-6. PubMed ID: 1604576
[No Abstract] [Full Text] [Related]
15. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
[No Abstract] [Full Text] [Related]
16. Induction of tolerance to small bowel allotransplants by mixed allogeneic chimerism.
Orloff MS; Orloff SL; DeMara EM; Coppage ML; Leong N; Fallon MA
Transplant Proc; 1994 Jun; 26(3):1585-6. PubMed ID: 8030048
[No Abstract] [Full Text] [Related]
17. Immunologic and metabolic consequences of in vitro and in vivo irradiation of small bowel allografts.
Stangl MJ; Langrehr J; Lee KK; Moynihan HL; Banner B; Schraut WH
Transplant Proc; 1990 Aug; 22(4):2058-9. PubMed ID: 2143873
[No Abstract] [Full Text] [Related]
18. The development of graft versus host disease in the immunologically compromised recipient of a small bowel allograft.
Moynihan HL; Stangl MJ; Langrehr J; Lee KK; Banner B; Schraut WH
Transplant Proc; 1990 Aug; 22(4):2055-7. PubMed ID: 2389520
[No Abstract] [Full Text] [Related]
19. Host vs graft and graft vs host reactions after allogeneic heterotopic small bowel transplantation in the rat.
Gasser M; Prange K; Schroeder P; Stoffregen C; Eckstein V; Deltz E
Transplant Proc; 1992 Jun; 24(3):1128-9. PubMed ID: 1604550
[No Abstract] [Full Text] [Related]
20. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
